| Income Statement |
| Total Revenue | 346.40B |
|
| Revenues (USD) | 51.24B |
| Cost of Revenue | 287.09B |
| Gross Profit | 59.31B |
| Operating Expenses | 54.76B |
| Research and Development Expense | 7.30B |
| Selling, General and Administrative Expense | 47.87B |
| Operating Income | 4.55B |
| Interest Expense | 708.00M |
| Income Tax Expense | 1.97B |
| Net Income | 7.13B |
| Net Income Common Stock | 7.13B |
| Net Income Common Stock (USD) | 1.05B |
| Consolidated Income | 8.69B |
| Net Income to Non-Controlling Interests | 1.56B |
| Earnings per Basic Share | 5.30 |
| Earnings per Basic Share (USD) | 0.78 |
| Earnings per Diluted Share | 5.02 |
| Dividends per Basic Common Share | 0.98 |
| Earning Before Interest & Taxes (EBIT) | 9.81B |
| Earning Before Interest & Taxes (USD) | 1.45B |
| Weighted Average Shares | 2.70B |
| Balance Sheet |
| Cash and Equivalents | 102.46B |
| Cash and Equivalents (USD) | 15.16B |
| Investments | 229.03B |
| Investments Current | 132.59B |
| Investments Non-Current | 96.44B |
| Trade and Non-Trade Receivables | 29.84B |
| Current Assets | 404.60B |
| Property, Plant & Equipment Net | 134.56B |
| Total Assets | 725.41B |
| Debt Current | 27.14B |
| Total Debt | 105.31B |
| Current Liabilities | 354.74B |
| Debt Non-Current | 78.17B |
| Total Liabilities | 443.03B |
| Shareholders Equity | 219.12B |
| Shareholders Equity (USD) | 32.41B |
| Assets Non-Current | 320.80B |
| Total Debt (USD) | 15.58B |
| Deferred Revenue | 3.14B |
| Deposit Liabilities | 40.98B |
| Goodwill and Intangible Assets | 72.25B |
| Inventory | 114.58B |
| Liabilities Non-Current | 88.30B |
| Trade and Non-Trade Payables | 230.63B |
| Tax Assets | 6.16B |
| Tax Liabilities | 13.72B |
| Cash Flow |
| Net Cash Flow from Financing | -19.89B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.90B |
| Capital Expenditure | -5.52B |
| Net Cash Flow from Investing | -29.53B |
| Net Cash Flow from Operations | 37.72B |
| Effect of Exchange Rate Changes on Cash | -1.21B |